Adaptyv Bio Secures $40 Million Series A for AI Protein Design Labs

Adaptyv Bio, a European biotechnology startup, has successfully raised, 34.35 million (approximately $40 million) in a Series A funding round. This capital infusion is earmarked for the development of its automated laboratory designed for agentic biology and…